...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Thoughts on ZCC

ZCC and Constellation Pharmaceuticals. Why the valuation difference? A valid question, but a different one.  I'm just looking at the reality of where we are.  With the stock where it is, the PPs look pretty good to me.

Share
New Message
Please login to post a reply